Informations:
Erreur:
ID
18703
Description
A Trial of Circumferential Pulmonary Vein Ablation (CPVA) Versus Antiarrhythmic Drug Therapy in for Paroxysmal Atrial Fibrillation (AF); ODM derived from: https://clinicaltrials.gov/show/NCT00340314
Lien
https://clinicaltrials.gov/show/NCT00340314
Mots-clés
Versions (1)
- 17/11/2016 17/11/2016 -
Téléchargé le
17 novembre 2016
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Atrial Fibrillation NCT00340314
Eligibility Atrial Fibrillation NCT00340314
- StudyEvent: Eligibility
Similar models
Eligibility Atrial Fibrillation NCT00340314
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Age
Item
1. age 18-70 years
boolean
C0001779 (UMLS CUI [1])
Symptomatic paroxysmal atrial fibrillation
Item
2. history of symptomatic paroxysmal af lasting more than 6 months. paroxysms of af are intended as recurrent self-terminating episodes lasting less than 7 days and occurring more than 2 times every month.
boolean
C0235480 (UMLS CUI [1])
Pregnancy
Item
1. pregnancy
boolean
C0032961 (UMLS CUI [1])
NYHA
Item
2. nyha functional class iii or iv
boolean
C1275491 (UMLS CUI [1])
left atrial size
Item
3. left atrial size > 65 mm
boolean
C0225860 (UMLS CUI [1,1])
C0456389 (UMLS CUI [1,2])
C0456389 (UMLS CUI [1,2])
LVEF
Item
4. left ventricular (lv) ejection fraction < 35%
boolean
C0428772 (UMLS CUI [1])
contraindication to anticoagulation with warfarin
Item
5. contraindication to anticoagulation with warfarin
boolean
C1301624 (UMLS CUI [1,1])
C0043031 (UMLS CUI [1,2])
C0043031 (UMLS CUI [1,2])
myocardial infarction
Item
6. history of myocardial infarction within six months of the procedure
boolean
C0027051 (UMLS CUI [1])
Catheter or surgical ablation attempt for af
Item
7. prior catheter or surgical ablation attempt for af
boolean
C2702800 (UMLS CUI [1])
C3520506 (UMLS CUI [2])
C3520506 (UMLS CUI [2])
Informed Consent
Item
8. inability or unwillingness to provide written informed consent
boolean
C0021430 (UMLS CUI [1])
life expectancy
Item
9. life expectancy less than 1 year
boolean
C0023671 (UMLS CUI [1])
Significant comorbid conditions such as: cancer, end stage renal disease, severe chronic obstructive lung disease, cirrhosis
Item
10. significant comorbid conditions such as: cancer (not cured), end stage renal disease (creatinine clearance < 20 ml/h), severe chronic obstructive lung disease, cirrhosis, etc)
boolean
C0009488 (UMLS CUI [1])
C0006826 (UMLS CUI [2])
C0373595 (UMLS CUI [3])
C0024117 (UMLS CUI [4])
C0023890 (UMLS CUI [5])
C0006826 (UMLS CUI [2])
C0373595 (UMLS CUI [3])
C0024117 (UMLS CUI [4])
C0023890 (UMLS CUI [5])
anticipated cardiac surgery for congenital, valvular, aortic or coronary heart disease
Item
11. anticipated cardiac surgery for congenital, valvular, aortic or coronary heart disease.
boolean
C0018821 (UMLS CUI [1,1])
C0152021 (UMLS CUI [1,2])
C0018821 (UMLS CUI [2,1])
C0018824 (UMLS CUI [2,2])
C0018821 (UMLS CUI [3,1])
C0003493 (UMLS CUI [3,2])
C0018821 (UMLS CUI [4,1])
C0010068 (UMLS CUI [4,2])
C0152021 (UMLS CUI [1,2])
C0018821 (UMLS CUI [2,1])
C0018824 (UMLS CUI [2,2])
C0018821 (UMLS CUI [3,1])
C0003493 (UMLS CUI [3,2])
C0018821 (UMLS CUI [4,1])
C0010068 (UMLS CUI [4,2])
left atrial thrombus
Item
12. presence of left atrial thrombus.
boolean
C3532827 (UMLS CUI [1])
antiarrhythmic drug therapy with amiodarone, sotalol and flecainide
Item
13. prior antiarrhythmic drug therapy with amiodarone, sotalol and flecainide at optimal doses (target 200 mg, 240 mg, 200 mg daily respectively
boolean
C0002598 (UMLS CUI [1])
C0037707 (UMLS CUI [2])
C0016229 (UMLS CUI [3])
C0037707 (UMLS CUI [2])
C0016229 (UMLS CUI [3])
Atrial fibrillation burden
Item
14. af burden < 2 episodes/month
boolean
C0004238 (UMLS CUI [1,1])
C4086638 (UMLS CUI [1,2])
C4086638 (UMLS CUI [1,2])
WPW Syndrome
Item
15. wpw
boolean
C0043202 (UMLS CUI [1])
Life Expectancy
Item
16. expected survival < 1 year
boolean
C0023671 (UMLS CUI [1])
contraindications for antiarrhythmics therapy including flecainide, sotalol or amiodarone
Item
17. contraindications for antiarrhythmics therapy including flecainide, sotalol or amiodarone not listed above:
boolean
C1301624 (UMLS CUI [1,1])
C0003195 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0002598 (UMLS CUI [2,2])
C1301624 (UMLS CUI [3,1])
C0037707 (UMLS CUI [3,2])
C1301624 (UMLS CUI [4,1])
C0016229 (UMLS CUI [4,2])
C0003195 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0002598 (UMLS CUI [2,2])
C1301624 (UMLS CUI [3,1])
C0037707 (UMLS CUI [3,2])
C1301624 (UMLS CUI [4,1])
C0016229 (UMLS CUI [4,2])
Left ventricular hypertrophy
Item
lv hypertrophy (lv mass index > 125g/m2)
boolean
C0149721 (UMLS CUI [1])
thyroid dysfunction
Item
thyroid dysfunction (hyperthyroidism or uncontrolled hypothyroidism or thyroid cancer)
boolean
C0348024 (UMLS CUI [1])
ALT, AST
Item
liver dysfunction (alt or ast >2x the reference values)
boolean
C0201836 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
C0201899 (UMLS CUI [2])
interstitial lung disease with dlco<70% of predicted or severe asthma
Item
interstitial lung disease with dlco<70% of predicted or severe asthma.
boolean
C1869044 (UMLS CUI [1])
C1516251 (UMLS CUI [2])
C0004096 (UMLS CUI [3])
C1516251 (UMLS CUI [2])
C0004096 (UMLS CUI [3])
QT interval
Item
qt interval exceeding 400 msec
boolean
C0429028 (UMLS CUI [1])
Sinus Node or AV Node Dysfunction
Item
symptomatic sinus node or atrioventricular node dysfunction unless a pacemaker had been implanted
boolean
C0428908 (UMLS CUI [1])
C0741301 (UMLS CUI [2])
C0741301 (UMLS CUI [2])
Myocardial ischemia
Item
evidence of stress-induced myocardial ischemia
boolean
C0151744 (UMLS CUI [1])